Braissant, O., Foufelle, F., Scotto, C., Dauca, M
#GLP1 #ObesityCare #Semaglutide #Tirzepatide #Retatrutide #MariTide #WeightManagement #DiabetesCare #PharmaceuticalIndustry #HealthcareInnovation To view or add a comment, sign in Retatrutide: The Next Big Breakthrough in Obesity Treatment
Lancet 392, 15191529
Although this is primarily relevant for the US, similar dynamics occur in the EU where some countries tender for a preferred GLP-1 (e.g., specific hospitals)
An analysis of the composition and diversity of snake venom
Our comprehensive service includes doctor consultations, ensuring that your treatment plan is tailored to your specific health profile and that any potential interactions or side effects are proactively managed